Hong Kong Pharmaceuticals Stock News

China Cinda Asset Management (SEHK:1359) has drawn fresh attention after reporting full year 2025 results that showed higher net income and earnings per share, along with a proposed 2025 cash dividend, both announced on March 31, 2026. See our latest analysis for China Cinda Asset Management. The latest full year results and proposed dividend have landed after a weak stretch for the share price. The 90 day share price return shows a 15.56% decline and the year to date share price return shows...

Earnings, board changes and new debt shape the latest picture for China Modern Dairy China Modern Dairy Holdings (SEHK:1117) just released full year 2025 results alongside board changes and a CNY 500 million 2.5% perpetual note issue, giving investors several moving parts to assess at once. See our latest analysis for China Modern Dairy Holdings. The share price has reacted to these updates, with a 1-day share price return of 4.96% and a 7-day share price return of 7.25%, while the 90-day...

A lackluster earnings announcement from China Shenhua Energy Company Limited ( HKG:1088 ) last week didn't sink the...

Recent share performance and business snapshot Haidilao International Holding (SEHK:6862) has seen mixed share performance, with a gain over the past week but a decline over the month. Returns over the past year and past 3 months remain negative. Against that backdrop, the company reports HK$43,225.355m in revenue and net income of HK$4,049.824m, with annual revenue growth of 6.51% and net income growth of 9.54%, mainly driven by its restaurant operations in Mainland China. See our latest...

Tianneng Power International Limited's ( HKG:819 ) healthy profit numbers didn't contain any surprises for investors...

The Hongkong and Shanghai Hotels, Limited's ( HKG:45 ) robust recent earnings didn't do much to move the stock. We...

In April 2026, Asian markets are navigating a complex landscape shaped by geopolitical tensions in the Middle East and fluctuating energy prices, impacting investor sentiment and economic indicators across the region. Despite these challenges, small-cap stocks have shown resilience, with some experiencing notable insider activity that could indicate potential value opportunities. Identifying promising small-cap stocks often involves assessing their ability to withstand market volatility while...

Despite UNQ Holdings Limited's ( HKG:2177 ) recent earnings report having lackluster headline numbers, the market...

ManpowerGroup Greater China Limited's ( HKG:2180 ) strong earnings report was rewarded with a positive stock price...

Earnings event puts Star Shine Holdings Group in focus Star Shine Holdings Group (SEHK:1440) is drawing attention after reporting full year 2025 results, with sales of CNY 513.79 million and a net loss of CNY 98.29 million from continuing operations. Compared with the prior year, sales were CNY 584.54 million, while net loss stood at CNY 12.75 million. Basic and diluted loss per share from continuing operations were CNY 0.078, higher than CNY 0.0101 a year earlier. See our latest analysis for...

Wharf (Holdings) (SEHK:4) is back in focus as it trades around its upcoming ex-dividend date on April 2, 2026. Recent institutional inflows and mixed technical signals are shaping short term sentiment. See our latest analysis for Wharf (Holdings). Recent trading has been choppy, with a 1 day share price return of 1.27% and a 7 day gain of 2.38%, set against a 30 day share price return showing a 10.62% decline. At the same time, the 1 year total shareholder return of 22.65% and 3 year total...

MiniMax Group (SEHK:100) has drawn attention after recent trading swings, with a 10.4% decline over the past day alongside strong year to date and monthly gains, prompting fresh questions about how investors value this AI platform stock. See our latest analysis for MiniMax Group. That sharp 10.4% one day share price return sits against a year to date share price return of 175.22% and a 30 day share price return of 17.88%, which may suggest that recent momentum is cooling after a strong...

Why China Risun Group’s latest earnings and dividend matter for shareholders China Risun Group (SEHK:1907) has drawn fresh attention after reporting full year 2025 results showing lower sales but higher net income, alongside a proposed final dividend for shareholders. The company reported 2025 sales of CNY 39,286.48 million, compared with CNY 47,542.74 million a year earlier. Net income was CNY 58.01 million versus CNY 20.13 million. Basic and diluted earnings per share from continuing...

Earnings and dividend update CIMC Enric Holdings (SEHK:3899) released full year 2025 results with sales of CN¥26,325.94 million and net income of CN¥1,135.21 million, alongside an annual dividend of HK$0.3100 per share. The company also reported basic earnings per share from continuing operations of CN¥0.561 and diluted earnings per share of CN¥0.555, figures that help you gauge how profits relate to each share owned. For income focused investors, the announced dividend is payable on June 29,...

Why United Energy Group’s latest results matter for shareholders United Energy Group (SEHK:467) just released its full year 2025 earnings, reporting sales of HK$19,191.27 million, lower net income compared with the previous year, and no recommended final dividend following a payout in the prior year. See our latest analysis for United Energy Group. United Energy Group’s share price has been volatile around the HK$0.55 level, with a 30 day share price return of a 32.93% decline contrasting...

On March 20, 2026, CF PharmTech, Inc. announced a cooperation under which JD Health International will be the exclusive online launch platform for several major new respiratory and rhinology products over the next three years, while also exploring internet-based chronic disease management models together. Alongside this, JD Health’s recent grant of 834,412 new share awards with strict clawback terms and its deeper role in digital drug commercialization highlight how the company is tying...

TravelSky Technology reported its full-year 2025 results in March 2026, with revenue of CNY 8,765.84 million and net income of CNY 2,341.56 million, alongside a proposed final cash dividend of CNY 0.276 per share, subject to shareholder approval at a future AGM. An interesting angle is that net income and earnings per share increased even as revenue edged down slightly, suggesting changes in cost control or business mix may have influenced profitability. Next, we will examine how the...

KLN Logistics Group (SEHK:636) released full year 2025 results, proposed a HK$0.16 per share final dividend, and outlined boardroom changes that reshuffle key executive and committee roles. See our latest analysis for KLN Logistics Group. At a share price of HK$6.64, KLN Logistics Group has seen a 1-year total shareholder return of 3.01%. However, its 3-year and 5-year total shareholder returns of 33.77% and 49.03% declines suggest longer term momentum has faded despite recent dividend and...

Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990) just received clearance from China’s drug regulator to begin clinical development of SKB103, its first TAA PD L1 bispecific antibody drug conjugate for advanced solid tumors. See our latest analysis for Sichuan Kelun-Biotech Biopharmaceutical. The SKB103 news arrives after a strong run in the shares, with a 30 day share price return of 30.37% and a year to date share price return of 25.69%. The 1 year total shareholder return of 108.06%...

CSPC Pharmaceutical Group (SEHK:1093) has drawn fresh attention after securing regulatory approval in China for its Aprepitant Injection, a next generation NK 1 antagonist aimed at preventing postoperative nausea and vomiting in adults. See our latest analysis for CSPC Pharmaceutical Group. Investors appear to be responding to a mix of product approvals, the 2025 earnings release and ongoing capital returns. A 1 year total shareholder return of 80.59% and a 90 day share price return of 9.22%...

Recent performance context for Sun Hung Kai Properties shares Sun Hung Kai Properties (SEHK:16) has drawn fresh attention after recent share price moves, with the stock showing a 1 day return of a 2.7% decline and a past month return of a 7.7% decline. Over the past 3 months, the shares show a 37.2% return, while the 1 year total return stands at 84.4%. Year to date, investors have seen a 35.6% total return, placing the current HK$131.00 price in a context of strong recent gains. See our...

Earnings jump and higher dividend put Yangtze Optical Fibre And Cable Limited (SEHK:6869) in focus Yangtze Optical Fibre And Cable Limited (SEHK:6869) has drawn attention after reporting full year 2025 results with higher sales, revenue and net income, alongside a raised final ordinary dividend announcement. See our latest analysis for Yangtze Optical Fibre And Cable Limited. At a latest share price of HK$189.0, Yangtze Optical Fibre And Cable Limited has seen strong momentum, with a 36.46%...

As global markets navigate the complexities of Middle East tensions and energy market volatility, Asian indices have shown mixed performance with Japan's markets experiencing declines while China's mainland indices remained relatively stable. In this environment, identifying undervalued stocks becomes crucial as investors seek opportunities that may offer potential value amid geopolitical uncertainties and fluctuating market conditions.

Amidst the backdrop of geopolitical tensions and energy market volatility, Asian markets are navigating a complex landscape. For investors willing to explore beyond established giants, penny stocks—often representing smaller or newer companies—remain an intriguing segment. Although the term "penny stocks" may seem outdated, these investments can still offer unique opportunities, particularly when backed by robust financials and potential for growth.